Skip to content

enGene via Forbion European (FRBN) deck

enGene is a clinical-stage biotechnology company developing non-viral gene therapies based on localized delivery of nucleic acid payloads to mucosal tissues.

This post is for subscribers only

Subscribe

Already have an account? Sign In

Latest